Inotiv, Inc. (NOTV)
NASDAQ: NOTV · Real-Time Price · USD
0.288
-0.003 (-1.13%)
At close: Apr 28, 2026, 4:00 PM EDT
0.288
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Inotiv Revenue
Inotiv had revenue of $120.88M in the quarter ending December 31, 2025, with 0.84% growth. This brings the company's revenue in the last twelve months to $514.03M, up 8.19% year-over-year. In the fiscal year ending September 30, 2025, Inotiv had annual revenue of $513.02M with 4.54% growth.
Revenue (ttm)
$514.03M
Revenue Growth
+8.19%
P/S Ratio
0.02
Revenue / Employee
$251,235
Employees
2,046
Market Cap
9.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 513.02M | 22.29M | 4.54% |
| Sep 30, 2024 | 490.74M | -81.69M | -14.27% |
| Sep 30, 2023 | 572.43M | 24.77M | 4.52% |
| Sep 30, 2022 | 547.66M | 458.05M | 511.19% |
| Sep 30, 2021 | 89.61M | 29.14M | 48.18% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MDxHealth | 107.88M |
| Biodesix | 88.50M |
| Exagen | 66.58M |
| XWELL | 29.21M |
| Precipio | 24.05M |
| bioAffinity Technologies | 6.16M |
| iSpecimen | 1.93M |
| Mainz Biomed | 537.08K |
NOTV News
- 2 months ago - Inotiv Provides Notice Regarding Cybersecurity Incident - GlobeNewsWire
- 2 months ago - Inotiv Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update - GlobeNewsWire
- 2 months ago - Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026 - GlobeNewsWire
- 3 months ago - Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery - GlobeNewsWire
- 4 months ago - Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities - GlobeNewsWire
- 5 months ago - Inotiv Earnings Call Transcript: Q4 2025 - Transcripts
- 5 months ago - Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update - GlobeNewsWire